GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearside Biomedical Inc (FRA:CLM) » Definitions » Pretax Margin %

Clearside Biomedical (FRA:CLM) Pretax Margin % : -2,389.38% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Clearside Biomedical Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Clearside Biomedical's Pre-Tax Income for the three months ended in Dec. 2024 was €-6.98 Mil. Clearside Biomedical's Revenue for the three months ended in Dec. 2024 was €0.29 Mil. Therefore, Clearside Biomedical's pretax margin for the quarter that ended in Dec. 2024 was -2,389.38%.

The historical rank and industry rank for Clearside Biomedical's Pretax Margin % or its related term are showing as below:

FRA:CLM' s Pretax Margin % Range Over the Past 10 Years
Min: -276060   Med: -2064.42   Max: 1.27
Current: -2064.36


FRA:CLM's Pretax Margin % is ranked worse than
81.06% of 1003 companies
in the Biotechnology industry
Industry Median: -134.73 vs FRA:CLM: -2064.36

Clearside Biomedical Pretax Margin % Historical Data

The historical data trend for Clearside Biomedical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearside Biomedical Pretax Margin % Chart

Clearside Biomedical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -230.68 1.27 -2,482.20 -394.92 -2,064.57

Clearside Biomedical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -76.16 -5,104.72 -8,398.81 -740.86 -2,389.38

Competitive Comparison of Clearside Biomedical's Pretax Margin %

For the Biotechnology subindustry, Clearside Biomedical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearside Biomedical's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearside Biomedical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Clearside Biomedical's Pretax Margin % falls into.


;
;

Clearside Biomedical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Clearside Biomedical's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-32.806/1.589
=-2,064.57 %

Clearside Biomedical's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-6.977/0.292
=-2,389.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clearside Biomedical  (FRA:CLM) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Clearside Biomedical Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Clearside Biomedical's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearside Biomedical Business Description

Traded in Other Exchanges
Address
900 North Point Parkway, Suite 200, Alpharetta, GA, USA, 30005
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Clearside Biomedical Headlines